Literature DB >> 33009196

The Muscle Morphology of Elite Sprint Running.

Robert Miller, Thomas G Balshaw1, Garry J Massey2, Sumiaki Maeo3, Marcel B Lanza4, Michael Johnston, Sam J Allen1, Jonathan P Folland1.   

Abstract

PURPOSE: This study aimed to investigate the differences in muscle volumes and strength between male elite sprinters, sub-elite sprinters, and untrained controls and to assess the relationships of muscle volumes and strength with sprint performance.
METHODS: Five elite sprinters (100-m season's best equivalent [SBE100], 10.10 ± 0.07 s), 26 sub-elite sprinters (SBE100, 10.80 ± 0.30 s), and 11 untrained control participants underwent 1) 3-T magnetic resonance imaging scans to determine the volume of 23 individual lower limb muscles/compartments and 5 functional muscle groups and 2) isometric strength assessment of lower body muscle groups.
RESULTS: Total lower body muscularity was distinct between the groups (controls < sub-elite +20% < elite +48%). The hip extensors exhibited the largest muscle group differences/relationships (elite, +32% absolute and +15% relative [per kg] volume, vs sub-elite explaining 31%-48% of the variability in SBE100), whereas the plantarflexors showed no differences between sprint groups. Individual muscle differences showed pronounced anatomical specificity (elite vs sub-elite absolute volume range, +57% to -9%). Three hip muscles were consistently larger in elite vs sub-elite (tensor fasciae latae, sartorius, and gluteus maximus; absolute, +45%-57%; relative volume, +25%-37%), and gluteus maximus volume alone explained 34%-44% of the variance in SBE100. The isometric strength of several muscle groups was greater in both sprint groups than controls but similar for the sprint groups and not related to SBE100.
CONCLUSIONS: These findings demonstrate the pronounced inhomogeneity and anatomically specific muscularity required for fast sprinting and provides novel, robust evidence that greater hip extensor and gluteus maximus volumes discriminate between elite and sub-elite sprinters and are strongly associated with sprinting performance.
Copyright © 2020 by the American College of Sports Medicine.

Entities:  

Mesh:

Year:  2021        PMID: 33009196     DOI: 10.1249/MSS.0000000000002522

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

Review 1.  Towards defining muscular regions of interest from axial magnetic resonance imaging with anatomical cross-reference: a scoping review of lateral hip musculature.

Authors:  Zuzana Perraton; Peter Lawrenson; Andrea B Mosler; James M Elliott; Kenneth A Weber; Natasha Ams Flack; Jon Cornwall; Rebecca J Crawford; Christopher Stewart; Adam I Semciw
Journal:  BMC Musculoskelet Disord       Date:  2022-06-04       Impact factor: 2.562

2.  Genomic predictors of testosterone levels are associated with muscle fiber size and strength.

Authors:  João Paulo L F Guilherme; Ekaterina A Semenova; Oleg V Borisov; Andrey K Larin; Ethan Moreland; Edward V Generozov; Ildus I Ahmetov
Journal:  Eur J Appl Physiol       Date:  2021-11-18       Impact factor: 3.078

3.  Hip Abductor and Adductor Rate of Torque Development and Muscle Activation, but Not Muscle Size, Are Associated With Functional Performance.

Authors:  Marcel Bahia Lanza; Kelly Rock; Victoria Marchese; Odessa Addison; Vicki L Gray
Journal:  Front Physiol       Date:  2021-10-14       Impact factor: 4.755

4.  Relationship of the knee extensor strength but not the quadriceps femoris muscularity with sprint performance in sprinters: a reexamination and extension.

Authors:  Miyuki Hori; Tadashi Suga; Masafumi Terada; Takahiro Tanaka; Yuki Kusagawa; Mitsuo Otsuka; Akinori Nagano; Tadao Isaka
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-06-10

5.  Sub-elite sprinters and rugby players possess different morphological characteristics of the individual hamstrings and quadriceps muscles.

Authors:  Raki Kawama; Masamichi Okudaira; Tatsuya Shimasaki; Hirohiko Maemura; Satoru Tanigawa
Journal:  PLoS One       Date:  2021-10-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.